351 related articles for article (PubMed ID: 11221841)
1. Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells.
Borrelli MJ; Schoenherr DM; Wong A; Bernock LJ; Corry PM
Cancer Res; 2001 Feb; 61(3):1113-21. PubMed ID: 11221841
[TBL] [Abstract][Full Text] [Related]
2. Heat-induced gene expression as a novel targeted cancer gene therapy strategy.
Huang Q; Hu JK; Lohr F; Zhang L; Braun R; Lanzen J; Little JB; Dewhirst MW; Li CY
Cancer Res; 2000 Jul; 60(13):3435-9. PubMed ID: 10910053
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
4. Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter.
Yu D; Jia WW; Gleave ME; Nelson CC; Rennie PS
Prostate; 2004 Jun; 59(4):370-82. PubMed ID: 15065085
[TBL] [Abstract][Full Text] [Related]
5. Control of transgene expression using local hyperthermia in combination with a heat-sensitive promoter.
Vekris A; Maurange C; Moonen C; Mazurier F; De Verneuil H; Canioni P; Voisin P
J Gene Med; 2000; 2(2):89-96. PubMed ID: 10809142
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo.
Li GC; He F; Shao X; Urano M; Shen L; Kim D; Borrelli M; Leibel SA; Gutin PH; Ling CC
Cancer Res; 2003 Jun; 63(12):3268-74. PubMed ID: 12810658
[TBL] [Abstract][Full Text] [Related]
7. Replicating adenoviral vector-mediated transfer of a heat-inducible double suicide gene for gene therapy.
Lee YJ; Galoforo SS; Battle P; Lee H; Corry PM; Jessup JM
Cancer Gene Ther; 2001 Jun; 8(6):397-404. PubMed ID: 11498759
[TBL] [Abstract][Full Text] [Related]
8. A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression.
Rubinchik S; Wang D; Yu H; Fan F; Luo M; Norris JS; Dong JY
Mol Ther; 2001 Nov; 4(5):416-26. PubMed ID: 11708878
[TBL] [Abstract][Full Text] [Related]
9. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific targeting using PSA promoter-based lentiviral vectors.
Yu D; Chen D; Chiu C; Razmazma B; Chow YH; Pang S
Cancer Gene Ther; 2001 Sep; 8(9):628-35. PubMed ID: 11593331
[TBL] [Abstract][Full Text] [Related]
11. Spatial and temporal control of transgene expression in vivo using a heat-sensitive promoter and MRI-guided focused ultrasound.
Guilhon E; Voisin P; de Zwart JA; Quesson B; Salomir R; Maurange C; Bouchaud V; Smirnov P; de Verneuil H; Vekris A; Canioni P; Moonen CT
J Gene Med; 2003 Apr; 5(4):333-42. PubMed ID: 12692867
[TBL] [Abstract][Full Text] [Related]
12. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
Laurie KL; Blundell MP; Baxendale HE; Howe SJ; Sinclair J; Qasim W; Brunsberg U; Thrasher AJ; Holmdahl R; Gustafsson K
Gene Ther; 2007 Dec; 14(23):1623-31. PubMed ID: 17851547
[TBL] [Abstract][Full Text] [Related]
13. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.
Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A
Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter.
Luna MC; Ferrario A; Wong S; Fisher AM; Gomer CJ
Cancer Res; 2000 Mar; 60(6):1637-44. PubMed ID: 10749134
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
18. Heat-directed gene targeting of adenoviral vectors to tumor cells.
Brade AM; Ngo D; Szmitko P; Li PX; Liu FF; Klamut HJ
Cancer Gene Ther; 2000 Dec; 7(12):1566-74. PubMed ID: 11228535
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer.
Xie X; Zhao X; Liu Y; Zhang J; Matusik RJ; Slawin KM; Spencer DM
Cancer Res; 2001 Sep; 61(18):6795-804. PubMed ID: 11559553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
